How many studies have been conducted on N Formylmethionine Leucyl Phenylalanine?

BiohacksAI has indexed 35 PubMed studies on N Formylmethionine Leucyl Phenylalanine. 26% of studies involve human subjects.

What are the main research areas for N Formylmethionine Leucyl Phenylalanine?

The primary research domains for N Formylmethionine Leucyl Phenylalanine are 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation. This is based on analysis of 35 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

N Formylmethionine Leucyl Phenylalanine

A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated.

35+ PubMed studies analyzed · Evidence Score: 39.9

Research Domains

N Formylmethionine Leucyl Phenylalanine has been studied across 15 research domains including 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation, 🦴 Bone & Joint, 🫁 Respiratory. The primary research focus is 🛡️ Immunity with 17% of studies addressing this area.

Loading evidence profile...

This evidence profile for N Formylmethionine Leucyl Phenylalanine is generated deterministically from 35 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.